Follow
C Patrick Reynolds
C Patrick Reynolds
Cancer Center Director, TTUHSC School of Medicine
Verified email at ttuhsc.edu - Homepage
Title
Cited by
Cited by
Year
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid
KK Matthay, JG Villablanca, RC Seeger, DO Stram, RE Harris, ...
New England Journal of Medicine 341 (16), 1165-1173, 1999
22251999
Determination of subcutaneous tumor size in athymic (nude) mice
MM Tomayko, CP Reynolds
Cancer chemotherapy and pharmacology 24, 148-154, 1989
19491989
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma
AL Yu, AL Gilman, MF Ozkaynak, WB London, SG Kreissman, HX Chen, ...
New England Journal of Medicine 363 (14), 1324-1334, 2010
18692010
Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy
MH Kang, CP Reynolds
Clinical cancer research 15 (4), 1126-1132, 2009
12912009
Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group …
KK Matthay, CP Reynolds, RC Seeger, H Shimada, ES Adkins, ...
Journal of clinical oncology 27 (7), 1007, 2009
9732009
Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma
CJ Thiele, CP Reynolds, MA Israel
Nature 313 (6001), 404-406, 1985
7771985
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children’s Oncology Group
WB London, RP Castleberry, KK Matthay, AT Look, RC Seeger, ...
J Clin Oncol 23 (27), 6459-65, 2005
6742005
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
M Sausen, RJ Leary, S Jones, J Wu, CP Reynolds, X Liu, A Blackford, ...
Nature genetics 45 (1), 12-17, 2013
5042013
The pediatric preclinical testing program: description of models and early testing results
PJ Houghton, CL Morton, C Tucker, D Payne, E Favours, C Cole, ...
Pediatric blood & cancer 49 (7), 928-940, 2007
4962007
Ceramide synthesis and metabolism as a target for cancer therapy
CP Reynolds, BJ Maurer, RN Kolesnick
Cancer letters 206 (2), 169-180, 2004
4492004
Retinoid therapy of high-risk neuroblastoma
CP Reynolds, KK Matthay, JG Villablanca, BJ Maurer
Cancer letters 197 (1-2), 185-192, 2003
3902003
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma
DL Baker, ML Schmidt, SL Cohn, JM Maris, WB London, A Buxton, ...
New England Journal of Medicine 363 (14), 1313-1323, 2010
3432010
The majority of total nuclear-encoded non-ribosomal RNA in a human cell is' dark matter'un-annotated RNA
P Kapranov, G St Laurent, T Raz, F Ozsolak, CP Reynolds, ...
BMC biology 8, 1-15, 2010
3292010
Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)-retinamide in neuroblastoma cell lines
BJ Maurer, LS Metelitsa, RC Seeger, MC Cabot, CP Reynolds
Journal of the National Cancer Institute 91 (13), 1138-1146, 1999
3261999
Antitumor activity of hu14. 18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study
S Shusterman, WB London, SD Gillies, JA Hank, SD Voss, RC Seeger, ...
Journal of Clinical Oncology 28 (33), 4969, 2010
3182010
Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines
N Keshelava, JJ Zuo, P Chen, SN Waidyaratne, MC Luna, CJ Gomer, ...
Cancer research 61 (16), 6185-6193, 2001
2922001
High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification.
N Hailat, DR Keim, RF Melhem, XX Zhu, C Eckerskorn, GM Brodeur, ...
The Journal of clinical investigation 88 (1), 341-345, 1991
2871991
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial
SG Kreissman, RC Seeger, KK Matthay, WB London, R Sposto, SA Grupp, ...
The lancet oncology 14 (10), 999-1008, 2013
2862013
Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma
TJ Moss, CP Reynolds, HN Sather, SG Romansky, GD Hammond, ...
New England Journal of Medicine 324 (4), 219-226, 1991
2821991
Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641
DR Strother, WB London, ML Schmidt, GM Brodeur, H Shimada, ...
Journal of clinical oncology 30 (15), 1842, 2012
2652012
The system can't perform the operation now. Try again later.
Articles 1–20